Supplier's Corner

Zanthin XP-3 Astaxanthin

March 19, 2012

Valensa has launched a new astaxanthin formulation designed to provide optimal absorption at lower use levels. Called Zanthin XP-3 astaxanthin, the new product combines Valensa’s Zanthin natural astaxanthin with a supercritical extract perilla seed oil, O2B peroxidation blocker stabilization system and sunflower-based phospholipids in a synergistic formulation that enhances the human body’s absorption of the astaxanthin. Rather than adopt a strategy of large Astaxanthin doses to ensure the optimal 2 mg to 4 mg intake levels research has shown the body can utilize, Zanthin XP-3 typically makes the Astaxanthin 90% available across the board. For further information: www.valensa.com

blog comments powered by Disqus
  • Nutricosmetics: Confined to Underdog Status or Opportunity to Outshine?

    Nutricosmetics: Confined to Underdog Status or Opportunity to Outshine?

    Nicholas Micallef , Euromonitor International||September 1, 2015
    Growing awareness that beauty is a byproduct of a healthy lifestyle is compelling more consumers to exercise and maintain a balanced diet.

  • Nature-Based Adipose Management Cosmetics

    Nature-Based Adipose Management Cosmetics

    John Stanek, Melinda Wochner and Shyam Gupta, CoValence Laboratories and Bioderm Research ||September 1, 2015
    The number of scientifically driven topical ingredients for body sculpting and adipose management is quickly growing.

  • Are You Aging Well?

    Are You Aging Well?

    Mark Menolascino, MD, Meno Clinic Center for Advanced Medicine||September 1, 2015
    How the future of anti-aging medicine and targeted nutritional supplementation will help achieve the optimal aging process.